An epidermotypic model of interface dermatitis reveals individual functions of fas ligand and gamma interferon in hypergranulosis, cytoid body formation, and gene expression

American Journal of Dermatopathology

Volumn 33, Issue 3, 2011, Pages 244-250

  Farley, Sherry M ^a,b   Wood, Lisa J ^a   Iordanov, Mihail S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

apoptosis; death ligand; death receptor; gene expression; inflammation

Indexed keywords

FAS LIGAND; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOID BODY; DERMATITIS; EPIDERMIS; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGRANULOSIS; INTERFACE DERMATITIS; LICHENOID; PRIORITY JOURNAL; PROTEIN FUNCTION; SKIN BIOPSY;

DERMATITIS; FAS LIGAND PROTEIN; GENE EXPRESSION; GENE EXPRESSION PROFILING; GRAFT VS HOST DISEASE; HUMANS; INTERFERON-GAMMA; ORGAN CULTURE TECHNIQUES;

EID: 79955523854     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181f1b200     Document Type: Article

References (35)

1. McKee PH, Calonje E, Granter SR. Pathology of the Skin with Clinical Correlations. 3rd ed. Elsevier Ltd; 2005.
2. Shlomchik WD. Graft-versus-host disease. Nat Rev Immunol. 2007;7: 340-352. (Pubitemid 46674485)
3. Vogelsang GB, Lee L, Bensen-Kennedy DM. Pathogenesis and treatment of graft-versus host disease after bone marrow transplant. Annu Rev Med. 2003;54:29-52. (Pubitemid 37386384)
4. Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol. 2007;25: 139-170. (Pubitemid 46697905)
5. Jacobsohn DA, Vogelsang GB. Acute graft versus host disease. Orphanet J Rare Dis. 2007;2:35.
6. Ferrara JL, Levy R, Chao NJ. Pathophysiologic mechanisms of acute graft-vs.-host disease. Biol Blood Marrow Transplant. 1999;5:347-356.
7. Niederwieser D, Herold M, Woloszczuk W, et al. Endogenous IFNgamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation. 1990;50:620-625. (Pubitemid 20358535)
8. Velardi A, Varese P, Terenzi A, et al. Lymphokine production by T-cell clones after human bone marrow transplantation. Blood. 1989;74: 1665-1672. (Pubitemid 19251544)
9. Reddy P, Ferrara JL. Immunobiology of acute graft-versus-host disease. Blood Rev. 2003;17:187-194. (Pubitemid 37356389)
10. Canninga-van Dijk MR, Sanders CJ, Verdonck LF, et al. Differential diagnosis of skin lesions after allogeneic haematopoietic stem cell transplantation. Histopathology. 2003;42:313-330. (Pubitemid 36459809)
11. Baker MB, Altman NH, Podack ER, et al. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med. 1996;183:2645-2656. (Pubitemid 26192373)
12. Braun MY, Lowin B, French L, et al. Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med. 1996;183:657-661. (Pubitemid 26059524)
13. Hattori K, Hirano T, Miyajima H, et al. Differential effects of anti-Fas ligand and anti-tumor necrosis factor alpha antibodies on acute graftversus host disease pathologies. Blood. 1998;91:4051-4055. (Pubitemid 28261965)
14. Weisdorf D. GVHD the nuts and bolts. Hematology Am Soc Hematol Educ Program. 2007;2007:62-67.
15. Farley SM, Dotson AD, Purdy DE, et al. Fas ligand elicits a caspaseindependent proinflammatory response in human keratinocytes: implications for dermatitis. J Invest Dermatol. 2006;126:2438-2451. (Pubitemid 44582266)
16. Farley SM, Purdy DE, Ryabinina OP, et al. Fas ligand induced proinflammatory transcriptional responses in reconstructed human epidermis: recruitment of the epidermal growth factor receptor and activation of map kinases. J Biol Chem. 2008;283:919-928.
17. Karaghiosoff M, Neubauer H, Lassnig C, et al. Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity. 2000;13:549-560.
18. Shimoda K, Kato K, Aoki K, et al. Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function. Immunity. 2000;13:561-571.
19. Minegishi Y, Saito M, Morio T, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006;25:745-755. (Pubitemid 46131400)
20. Iordanov MS, Choi RJ, Ryabinina OP, et al. (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor. Mol Cell Biol. 2002;22:5380-5394. (Pubitemid 34755750)
21. Iordanov MS, Sundholm AJ, Simpson EL, et al. Cell death-induced activation of epidermal growth factor receptor in keratinocytes: implications for restricting epidermal damage in dermatitis. J Invest Dermatol. 2005;125:134-142. (Pubitemid 40981434)
22. Poumay Y, Dupont F, Marcoux S, et al. A simple reconstructed human epidermis: preparation of the culture model and utilization in in vitro studies. Arch Dermatol Res. 2004;296:203-211. (Pubitemid 39506516)
23. Holler N, Tardivel A, Kovacsovics-Bankowski M, et al. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol Cell Biol. 2003;23:1428-1440. (Pubitemid 36177050)
24. Gerritsen MJ, van Erp PE, van Vlijmen-Willems IM, et al. Repeated tape stripping of normal skin: a histological assessment and comparison with events seen in psoriasis. Arch Dermatol Res. 1994;286:455-461. (Pubitemid 24324721)
25. Szabo SJ, Kim ST, Costa GL, et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000;100:655-669.
26. Szabo SJ, Sullivan BM, Stemmann C, et al. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science. 2002;295:338-342. (Pubitemid 34074366)
27. Glimcher LH. Trawling for treasure: tales of T-bet. Nat Immunol. 2007;8: 448-450. (Pubitemid 46605908)
28. Weedon D, Searle J, Kerr JF. Apoptosis. Its nature and implications for dermatopathology. Am J Dermatopathol. 1979;1:133-144. (Pubitemid 11219277)
29. Sugerman PB, Faber SB, Willis LM, et al. Kinetics of gene expression in murine cutaneous graft-versus-host disease. Am J Pathol. 2004;164:2189.
30. Piper KP, Horlock C, Curnow SJ, et al. CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation. Blood. 2007;110: 3827-3832. (Pubitemid 350248437)
31. Varona R, Cadenas V, Lozano M, et al. CCR6 regulates the function of alloreactive and regulatory CD4+ T cells during acute graft-versus-host disease. Leuk Lymphoma. 2006;47:1469-1476. (Pubitemid 44364009)
32. Frederick MJ, Henderson Y, Xu X, et al. In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am J Pathol. 2000;156:1937-1950. (Pubitemid 30641763)
33. Kurth I, Willimann K, Schaerli P, et al. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J Exp Med. 2001;194:855-861. (Pubitemid 32983020)
34. Schaerli P, Willimann K, Ebert LM, et al. Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. Immunity. 2005;23:331-342. (Pubitemid 41317799)
35. Shurin GV, Ferris RL, Tourkova IL, et al. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. J Immunol. 2005;174: 5490-5498. (Pubitemid 40593189)